abstractcover2016...ebony irby the union—nar new york, ny, usa president-elect: victoria cook, md...

____________________________________________

20th Annual TB Conference

CONTINUING EDUCATION CREDITS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the

Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Curry

International Tuberculosis Center, the National Tuberculosis Controllers Association, and the International Union

Against TB and Lung Disease-North America Region. The Curry International Tuberculosis Center is accredited by the

ACCME to provide continuing medical education for physicians. This conference is approved for up to 24 continuing

education hours.

The Curry International Tuberculosis Center designates this educational activity for a maximum of up to 24 AMA PRA

Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the

activity.

The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State

Board of Registered Nursing, Provider Number CEP 12308. This conference is approved for up to 24 continuing

education contact hours.

Please note: Up to 24 continuing nursing education credits (CNE)/contact hours will be available to attendees of the

training. New California Board of Registered Nursing licensing and certification guidelines require that you attend the

entire conference in order to receive CE credit (a 15-minute grace period will be offered at the beginning of the day).

Board requirements prevent us from offering credit to people who arrive more than 15 minutes after the start of the

training, or leave the training early. Therefore, partial credit will not be awarded.

Certificates will be mailed approximately 8-10 weeks after the course to all participants who requested credits on their

applications and who successfully complete the course. Successful completion includes signing-in each day, attending

the entire course and completing and turning in an evaluation form, and—for physician learners—participating in one

longer-term post-course activity (survey).

2

The Union - NAR and NTCA 20th Annual TB Conference

MESSAGES 3

PROGRAM AT A GLANCE 5

COMMITTEES 7

KEYNOTE SPEAKERS 10

AWARDS 12

DAILY SCHEDULE 20

TABLE OF CONTENTS

3 February 24—27, 2016, Sheraton Denver Downtown Hotel

On behalf of the North American Region of the IUATLD, I welcome you to the 20th Annual TB Conference February 24-27, 2016 in Denver. The 2016 meeting is a combined conference with the National TB Controllers Association, and the Planning Committee, Co-chaired by Drs. Alfred Lardizabal and John Bernardo has developed an exciting agenda for all of us as we look forward to implementing the End TB Strategy. Please note the Pre-Event Meetings on February 23-24 will include TB Survivors Communication Training, NTCA meetings and Post-Graduate Courses on epidemiology, use of digital tools and social media, and basic science research.

MESSAGES

RANDALL REVES, MD

President, The Union-North America Region

ROBERT BELKNAP, MD

President, National Tuberculosis Controllers Association

Welcome to the 20th annual meetings of the National TB Controller’s Association and the Union-North America Region, and the first combined meeting. We share the goal of a world free from tuberculosis. Progress requires the coordinated efforts of dedicated professionals in public health, research and clinical care, as well as the communities most affected. This meeting brings together all these groups and I am excited to have it in my home town of Denver.

4


It is with great pleasure that we welcome you to the TB 2016 Conference – a particularly important event this year as it is the 20th Annual Meeting of both the North American Region of the International Union Against Tuberculosis and Lung Disease and the National Tuberculosis Controllers Association of the United States – the first time both organizations are holding a joint conference. This year’s agenda includes wide ranging clinical, scientific, and programmatic topics. Particular focus is given to pediatric tuberculosis, drug resistant TB, TB genomics in public health practice, and exploring various present day social issues such as the migration of unaccompanied minors and homelessness. Pre-meeting events will include the traditional NTCA section meetings, a TB scientific symposium, an epidemiology workshop, as well as a social media training workshop. In addition, the second Communications Training for TB Survivors will be co-located with the conference and participants will be invited to join us so that their voices, and stories, can add to the richness of the agenda and inspire us to continue our fight to eliminate TB. Our thanks to the planning committee and the staff of the British Columbia Lung Association and the National Tuberculosis Controllers Association for their hard work and commitment to ensure the success of this annual conference.

ALFRED LARDIZABAL, MD

The Union-North America Region

2016 CONFERENCE PLANNING COMMITTEE CO-CHAIRS

JOHN BERNARDO, MD

National Tuberculosis Controllers Association


TUESDAY, February 23, 2016

Pre-Event Meetings

TB Survivor Communications Training (Tower Court D) Annual Meeting of the US-Affiliated Pacific Islands TB Control Programs (Tower Court C) NTCA Board Meeting (Tower Court A) Challenges and Issues in Ensuring High Quality TB Surveillance Data (Tower Court B)

Targeted Outreach Strategies for High-TB Burden Populations: A Discussion Forum (Windows) NTCA Business Meeting/Town Hall (Grand Ballroom 1)

WEDNESDAY, February 24, 2016

Pre-Event Meetings

TB Survivor Communications Training (Tower Court D) NSTC Annual Meeting (Grand Ballroom I)

IGRA Best Practices

Xpert for Release from Isolation

Beyond the Cookbook (There’s No Recipe for That!)

Exploding Head Zone – The Interface of Molecular and Growth-Based Drug Susceptibility Testing

What in the World Are We Going to Do About Childhood Tuberculosis?

When Patients’ Needs Exceed Available Resources—What Do I Do and Where Can I Turn?

NTNC Annual Meeting (Grand Ballroom II)

Learning from the Past: MDR-TB: What Nurses Can Do to Make Treatment Bearable

Preparing for the Future: Partnerships to Treat LTBI, Training New TB Nurses, and Contributing to the Development of TB Guidelines

SETC Annual Meeting (Tower Court A)

Talking Shop in the Mile-High City

Post-Graduate Courses

Using Epidemiology for Data-Driven Decision-Making in TB Programs (Grand Ballroom I)

IMDP’s Digital Tools and Social Media for Public Health (Tower Court D)

Advances in the Science and Practice in Tuberculosis Control (Grand Ballroom II)

Other Meetings

NAR Council/Executive Committee Meeting (Aspen Room)

Stop TB USA Coordinating Board Meeting (Aspen Room)

THURSDAY, February 25, 2016 Grand Ballroom

STOP TB Meeting

Progress, Challenges toward the Goal of Global TB Elimination

Modelling on the Transmission Phase of TB Elimination

TB Elimination in Canada: Can We Get There?

TB Elimination: California Dreamin’

TB Elimination in the Caribbean: The Suriname Experience

PAHO’s Pilot TB Program: Framework of TB Control in Large Cities

Oral Abstract Presentation: Identifying Gaps in Tuberculosis Prevention Among Adults at an Urban, Public Health Clinic: An LTBI Care Continuum

Lunch Break Stop TB Canada (Tower Court A) and Stop TB USA Meetings (Tower Court D)

PROGRAM-AT-A-GLANCE

6


FRIDAY, February 26, 2016 Grand Ballroom

Current Issues on Pediatric TB

The Epidemiology, Clinical Characteristics and Outcomes of Pediatric Central Nervous System Tuberculosis in California from 1993-2011; A Search for Modifiable Clinical and Epidemiological Risk Factors

Treatment Outcomes of Childhood Tuberculous Meningitis: A Systematic Review of TB Meningitis

New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents

School Outbreaks and Exposures - Best Practices and Management

Oral Abstract Presentation: Latent Tuberculosis in Pregnancy: A Systematic Review

Lunch Break/Annual Business Meeting

TB Genomics in Clinical and Public Health Practice

Introduction to the TB Genome

The Impact of Genomics Era on Mycobacterium tuberculosis Research

Implementing WGS as a Clinical Decision Making Tool

Tracking TB in the Canadian North: Detecting Outbreaks among Founder Strains

Reconstructing TB Outbreaks with Genomics: Lessons from an Outbreak in BC Homeless Shelter

Oral Abstract Presentation: Latent Tuberculosis in Pregnancy: A Systematic Review

Awards Ceremony and Poster Session

Nursing Sponsored Session: TB Elimination through Collaborative Partnerships

Paramedics...Responding to More than Shootings and Heart Attacks

3 P’s: Pharmacist, Pills, and PPDs

College Entrance: SAT, ACT and Now a TST and IGRA too?

Oral Abstract Presentation: Family-Centered Approach to TB Care

The Beyond TB Lecture - One Health: Beyond Medicine The George Comstock Lecture - Global Scale-up of the Management of Drug-resistant Tuberculosis: Why is this so hard?

Industry-Sponsored Satellite Symposium 1: QuantiFERON - Insights for Research & Practitioners

SATURDAY, February 27, 2016 Grand Ballroom

Meet the Professor

Public Health is Local: One Size Doesn’t Fit All

Overview of the Unaccompanied Children with TB

Texas Interfaith Welcome Coalition: Personal Perspectives

Homelessness, Housing, and Tuberculosis: The National Picture The Local Picture: Atlanta, Georgia

The Local Picture: Seattle King County, Washington

HUD: National Program with Housing Solutions

Oral Abstract Presentation: Cost-effectiveness of Targeted Testing and Treatment for Latent Tuberculosis Infection among Foreign-born Persons in the United States

Lunch Break

Industry-Sponsored Satellite Symposium 2 - Diabetes & Tuberculosis: Converging Epidemics and their Impact on Patient Care

Drug Resistant Session

Treatment of MDR in Pregnancy; Results of a Systematics Review

Low Level Rifampin Resistance: Diagnostic Challenges and Treatment Outcomes

Impact of the Number of Drugs, Treatment Duration and PZA on MDR TB Treatment Outcomes

Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and its Newer Relatives

Oral Abstract Presentation: Enhancing Management of Tuberculosis Treatment with Video Directly Observed Therapy


Immediate Past President: Pamela Orr, MD

University of Manitoba Winnipeg, MB, Canada

Secretary/Treasurer:

James Johnston, MD, MPH BC Centre for Disease Control

Vancouver, BC, Canada

Past Vice-President: Kevin Schwartzman, MD, MPH

McGill University Montreal, QC, Canada

Ex-Officio:

Scott McDonald British Columbia Lung Association


Ebony Irby The Union—NAR

New York, NY, USA

President-Elect: Victoria Cook, MD

BC Centre for Disease Control Vancouver, BC, Canada

Secretariat:

Menn Biagtan, MD, MPH British Columbia Lung Association


President: Randall Reves, MD, MSc

Denver Public Health Department Denver, CO, USA

Program Chair/Vice-President: Alfred Lardizabal, MD

NJMS Global Tuberculosis Institute at Rutgers Newark, NJ, USA

NAR Executive Committee

COMMITTEES

NTCA Board of Directors

President: Robert Belknap, MD

Denver, CO

President-Elect: Peter Davidson, PhD

Lansing, MI

Immediate Past President: John Bernardo, MD

Boston, MA

NTNC President: Deborah Isaacks, RN, BSN

Santa Fe, NM

Treasurer: Julie Higashi, MD, PhD

Los Angeles, CA

NSTC President: Marcos Burgos, MD

Albuquerque, NM

Secretary: Diana Fortune, RN, BSN

Santa Fe, NM

SETC President: Shama Ahuja, PhD New York City, NY

Nancy Baruch, RN, MS, MBA Baltimore, MD

Janet Candido Springfield, IL

Maureen Murphy-Weiss, BSN, RN, CPM

Columbus, OH

Naveen Patil, MD, MHSA, MA Little Rock, AR

Kristin Rounds Pierre, SD

Dr. Rose-Marie Sales, MPH

Atlanta, GA

TB Program Representatives

8


Faculty Dr. Lisa Armitige

Heartland National TB Center, San Antonio, TX, USA

Ms. Nisha Ahamed Rutgers Global Tuberculosis Institute, Newark, NJ, USA

Dr. Pennan Barry

California Department of Public Health, Richmond, CA, USA

Dr. Robert Belknap Denver Health, Denver, CO, USA

Mr. David Canavan

HUD, Washington, DC, USA

Dr. Silvia Chiang Baylor College of Medicine, Houston, TX, USA

Dr. Eric Commiesie Ministry of Health, Paramaribo, Suriname

Dr. Charles Daley

National Jewish Health, Denver, CO, USA

Dr. Rebecca Davidson National Jewish Health, Denver, CO, USA

Ms. Marianne Gaye-Ayrault

The Union, Paris, France

Dr. Mirtha del Granado PAHO, Washington, DC, USA

Dr. Ed Desmond


Dr. David Dowdy Johns Hopkins University, Baltimore, MD, USA

Dr. Jennifer Flood


Dr. Kevin Fennelly National Heart, Lung, and Blood Institute, Bethesda, MD, USA

Ms. Diana Fortune

New Mexico Department of Public Health, Santa Fe, NM, USA

Dr. Jennifer Gardy BC Centre for Disease Control, Vancouver, BC, Canada

Mr. Phil Griffin

Kansas Department of Health, Topeka, KS, USA

Ms. Michelle Haas Denver, CO, USA

Dr. John Jereb

Office of Refugee Resettlement, Washington, DC, USA

Dr. James Johnston BC Centre for Disease Control, Vancouver, BC, Canada

Dr. Alexander Kay


Ms. April King-Todd Los Angeles County Department of Public Health, Los Angeles,

CA, USA

Dr. Robyn Lee McGill University, Montreal QC, Canada

Dr. Richard Long University of Alberta, Edmonton, AB, Canada

Dr. Knut Lönnroth

World Health Organization, Geneva, Switzerland

Dr. Sapna Morris Centers for Disease Control and Prevention, Atlanta, GA, USA

Dr. Carole Mitnick

Partners in Health/Harvard University, Boston, MA, USA

Dr. Kimberlee Musser New York State Department of Health, Albany, NY, USA

Mr. Larry Niler

Utah Department of Health, Salt Lake City, UT, USA

Dr. Edward Nardell Harvard School of Public Health, Boston, MA, USA

Dr. Masa Narita

Public Health Seattle, Seattle, WA, USA

Ms. Catalina Navarro Heartland National TB Center, San Antonio, TX, USA

Dr. Francisco J. Olea-Popelka


Dr. Shaheed Vally Omar South African National Institute for Communicable Disease,

Cape Town, South Africa

Dr. Farah Parvez Centers for Disease Control and Prevention, Atlanta, GA, USA

Zee Pinkerton Olathe, KS, USA

Dr. James Posey

Centers for Disease Control and Prevention, Atlanta, GA, USA

Dr. Susan Ray Emory University, Atlanta, GA, USA

Ms. Eva Reeder

American Medical Response/Ventura County Public Health, Ventura, CA, USA

Dr. Randall Reves

Denver Department of Health, Denver, CO, USA

Dr. Maunank Shah Johns Hopkins University, Baltimore, MD, USA


Dr. Neha Shah Centers for Disease Control and Prevention, Atlanta, GA, USA

Dr. David R. Sherman

Seattle Biomedical Research Institute, Seattle, WA, USA

Dr. Jeffrey Starke Baylor Medical Center, Houston, TX, USA

Mr. Mike Taigman

American Medical Response/Ventura County Public Health, Ventura, CA, USA

Ms. Mai Vu San Francisco VA Medical Center, San Francisco, CA, USA

Dr. Nick Walter

Denver VA Medical Center, Denver, CO, USA

Ms. Patty Woods Rutgers Global TB Institute, Newark, NJ, USA

Ms. Teresa Wortmann

Missouri Department of Health, Jefferson City, MO, USA

Faculty

CME Planning Committee

Alfred Lardizabal, MD (Co-Chair) NJMS Global Tuberculosis Institute at Rutgers

Newark, NJ, USA

John Bernardo, MD (Co-Chair) Boston University School of Medicine

Boston, MA, USA

Lisa Armitige, MD, PhD Heartland National TB Center

San Antonio, TX, USA

Carolyn Bargman, RN-C, MA Denver Metro TB Clinic

Denver, CO, USA

Victoria Cook, MD BC Centre for Disease Control


Jennifer Flood, MD, MPH California Department of Public Health

Richmond, CA, USA

Jennifer Gardy, PhD BC Centre for Disease Control


Marianne Gaye-Ayrault, MBA The Union

Paris, France

James Johnston, MD, MPH BC Centre for Disease Control


Ian Kitai, MD The Hospital for Sick Children

Toronto, ON, Canada

Anna Mandalakas, MD Baylor College of Medicine

Houston, TX, USA

Sundari Mase, MD, MPH Centers for Disease Control and Prevention

Atlanta, GA, USA

Kelly Musoke, MPH Curry International TB Center/UCSF

San Francisco, CA, USA

Edward Nardell, MD Harvard School of Public Health

Boston, MA, USA

Elizabeth Rea, MD Toronto Public Health Toronto, ON, Canada

Randall Reves, MD, MSc

Denver Public Health Department Denver, CO, USA

Max Salfinger, MD

National Jewish Health Denver, CO, USA

Barbara Seaworth, MD

Heartland National TB Center San Antonio, TX, USA

James Sederberg

Curry International TB Center/UCSF San Francisco, CA, USA

Kevin Schwartzman, MD, MPH

McGill University Montreal, QC, Canada

Lana Kay Tyer, RN, MSN

Department of Health Olympia, WA, USA

Teresa Wortmann, RN

Missouri Department of Health and Senior Services Jefferson City, MO, USA

10


KEYNOTE Speakers

Dr. Francisco J. Olea-Popelka is a veterinarian with a PhD in Epidemiology.

His work focuses on diseases and health challenges at the interface of domestic species (dogs, cats, cows, pigs, horses), wildlife (badgers, elephants, lions, rhinoceroses), and humans in different environments, globally.

He is the former chair of the Union Zoonotic TB sub-section and currently he is a scientific advisor for the Union, Irish Department of Agriculture, Disney World Animal Kingdom, and Kruger National Park in South Africa.

When The Union was founded in 1920, the organizers rallied around the dream to eliminate tuberculosis as

a public health threat. Since that time, we have seen the development of effective drugs, the development

and implementation of the DOTS strategy, the identification of the linkages between poverty and TB, and

the introduction of new diagnostic technologies. Yet, TB remains a global threat. The Beyond TB lecture of

the NAR annual meeting serves to focus attention on forces outside of the traditional TB world, assisting us

to look beyond the usual partners, usual paths, and usual solutions to innovation and novel public health

strategies to achieve our goal- A World Free of TB. This year’s Beyond TB Lecture is presented by Dr.

Francisco J. Olea-Popelka.

DR. FRANCISCO J. OLEA-POPELKA


Beyond TB Lecture


The 11th George Comstock Session is organized in this conference to acknowledge his work over the past

several decades. His direct and personal involvement in advanced research of tuberculosis spans the period

of early BCG trials to the modern era of molecular biology. His steadfast advocacy of good and tremendous

depth of wisdom solidly based on experience has been the guiding force for all the workers in the various

fields of tuberculosis research all around the world, particularly in the United States. His mentorship has led

us to wise investments in research in tuberculosis prevention. This year’s George Comstock Lecture is

presented by Dr. Charles Daley.

DR. CHARLES DALEY


George Comstock Lecture

Charles (Chuck) Daley, MD, is Professor of Medicine at National Jewish Health (NJH) and the University of Colorado Denver. He is Chief of the Division of Mycobacterial and Respiratory Infections and Director of the Nontuberculous Mycobacteria (NTM) Center of Excellence at NJH. Dr. Daley is the chair of the Global Drug Resistant Tuberculosis Initiative for the Stop TB Partnership and Chair of the Scientific and Technical Advisory Group for the Global TB Program at the World Health Organization.

12


Mike Iseman is the epitome of a gentleman physician/scholar and someone who dedicated his entire career to studying mycobacteria and caring for patients with mycobacterial diseases. He is a true giant in the field.

Dr. Iseman served as Chief of the Clinical Mycobacteriology Service from 1982 to 2004. During his leadership, the mycobacterial service evolved from the leading MDR-TB treatment program to one of the premier clinical programs for treatment of nontuberculous mycobacterial infections. During his tenure, he taught many of us about mycobacteria and how to be better clinicians and he taught all of us how to be better people.

He served as Editor-in-Chief of Tubercle and Lung Disease and then the first Editor-in-Chief of the International Journal of Tuberculosis and Lung Disease from 1997 to 2002. His knowledge of mycobacteria, facility with the English language and perfect prose are renowned.

As a teacher, Dr. Iseman is unequalled. He ran the Denver TB Course from 1983 until his retirement two years ago. Thousands of people have taken this course, the longest running TB course in the U.S. Who cannot remember his chest x-ray contests!

He was the author of one of the most widely read text on tuberculosis entitled, A Clinician’s Guide to Tuberculosis: a true classic in the field. He has published over 175 research manuscripts, book chapters, reviews, and editorials. His 1993 publication in the NEJM on how to treat multidrug-resistant TB was the roadmap that the world followed.

Dr. Iseman has received numerous awards for his dedicated service including The James D. Bruce Public Health Award (American College of Physicians), Edward Livingston Trudeau Medal (ATS), F. Murray Kornfeld Award (American College of Chest Physicians) and in 2010 the Lifetime Achievement Award at National Jewish Health.

Given his dedication to our art and our patients, and his many accomplishments, Mike is richly deserving of The Union-NAR Lifetime Achievement Award.

Lifetime Achievement Award

DR. MICHAEL D. ISEMAN



Dr. Walton’s steadfast belief in the importance of education as a

means to eliminate TB has, and continues to, influence critical

decisions on policy and funding related to TB education and

training in the United States and internationally. Those who have

had the pleasure to work alongside her cannot help but adopt for

their own her oft repeated sentiment, “Efficient TB programs are

not run by poorly trained or poorly educated staff.”

Within the U.S., Dr. Walton has staunchly supported allocating

CDC funds for education and training to U.S. states and territories.

She had key roles in defining the primary purpose of the CDC's TB

Regional Training and Medical Consultation Centers and

developing the U.S. National Strategic Plan for Tuberculosis

Training and Education. Internationally, as a participant in the

WHO’s Strategic Technical Advisory Group for TB, she has

promoted education and training during meetings to develop the Stop TB Strategy and the End TB Strategy

2016-2035.

It is simply not possible to quantify Dr. Walton’s contributions to ending TB. Her visionary approach and

decisions are often mirrored by other nations. For more than 25 years, her talent, enthusiasm, commitment

to creating and sharing knowledge and resources, and building capacity from within has been preparing and

inspiring countless of educators around the world to do the same. As a result, her efforts have strengthened

TB prevention and control from frontlines to boardrooms, all over the world.

DR. WANDA WALTON

Centers for Disease Control and Prevention, Atlanta, GA, USA

Lifetime Achievement Award

14


Since 1999 Dennis has been the Medical Director of the Edmonton TB Clinic and de facto, the Co-Director along with Provincial TB Consultant of the TB Inpatient Unit at the University of Alberta Hospital, the latter receiving patients from the city of Edmonton and all of rural Alberta. In addition to these positions of leadership in the TB Program of Alberta, he has held multiple leadership positions in the Department of Medicine, Faculty of Medicine and Dentistry at the University of Alberta. These include Acting Chair of the Department and currently Vice-Dean, Faculty Affairs, Faculty of Medicine and Dentistry. With his training in immunology and molecular biology at Bethesda, Maryland in 1985-1988, Dennis along with Dr. Marcel Behr in Montreal, were for many years Canada’s leading experts in TB molecular diagnostics. In that regard, Dennis played a central role in the development of Alberta’s 25 year, DNA fingerprint database at the Provincial Laboratory for Public Health (since 1991 all Mycobacterium tuberculosis isolates in the province have been archived and fingerprinted). He is exceptionally bright and a more dedicated TB physician

you could not find. His research, which is substantial, extends to new drug development and new diagnostics. He, along with Dr. Madhukar Pai at the University of Montreal, are widely regarded as Canada’s leading experts in Interferon Gamma Release Assays. Other strengths include a deep understanding of HIV-TB interaction and both TB and HIV pharmacotherapy. He is a most caring, honest and committed bedside physician. It is a great pleasure for all of the TB physicians in Alberta and all of the staff of the Edmonton TB clinic to nominate Dennis for a service award.

DR. DENNIS KUNIMOTO

University of Alberta, Edmonton, AB, Canada

Service Award


The idea for the Pittsfield Anti-Tuberculosis Association began at a small community meeting in 1907 in

Pittsfield, Massachusetts, in response to the pleas of three local physicians to do something for the

“prevention and relief of tuberculosis.” Their efforts began with raising funds to support tuberculosis

education, a nurse, and a day camp for consumptives. With great energy and fund raising activities, the camp

evolved into a hospital for tuberculosis to serve the people around Pittsfield. After nearly forty years of

running its own hospital, the Association turned its efforts to funding activities in other institutions to fulfill

its charter to “work to conquer TB.” Early funds and grants in the 1950's included funds to establish the

outpatient TB clinic in Pittsfield and to purchase badly needed x-ray and laboratory equipment at

Massachusetts’ universities. In 1964, the first of a series of national meetings on TB and lung diseases was

sponsored by the Association and held in Pittsfield. In 1968, the Association expanded its horizons by

donating $25,000, as well as expert clinical consultation, to TB control efforts in Laredo, Texas, then facing

high rates of the disease. The extensive record of local, state, national and international contributions by the

Pittsfield Anti-Tuberculosis Association is too long to list. Its generous support to The Union-North America

Region has made the travel grant awards possible.

Pittsfield Anti-Tuberculosis Association

Travel Grant Awards

16


Travel Grant Awards INTERNATIONAL

Towshema Hardyal has been with the National Tuberculosis Programme, Ministry of Public Health as an Administrative Professional since 2010. She has been exposed to numerous Administrative Professional workshops and is a certified Tuberculosis Peer Educator. Ms. Hardyal has a keen interest in facilitating an environment that fosters efficient and effective health care to the public and aims to continue pursuing studies in this field.

Lily Bonadonna has been collaborating with the Peruvian National Institute of Health in Lima, Peru since August, 2014. She graduated with a Bachelor of Science in Anthropology from the University of Michigan in May, 2014 and was awarded the Raoul Wallenberg Fellowship. Through this fellowship, she designed a qualitative research study that investigated the social determinants contributing to diagnostic delay of tuberculosis in Lima, Peru.

MS. TOWSHEMA HARDYAL,

MS. LILY BONADONNA,

Diana Khan has been with the National Tuberculosis Programme, Ministry of Health, Guyana, since 2007. She is currently the Programme’s Monitoring and Evaluation Coordinator and a candidate in the Master’s of Public Health programme at the University of Guyana. As part of her routine programmatic evaluation duties, she recently conducted an assessment on status of MDR-TB in Guyana.

MS. DIANA KHAN,

Dr. Milo Richard has been working at the National TB Program Haiti since 2005, where he has served as the chief of patient care section for two years. After his Master in Public Health in 2009, he became the head of the monitoring and evaluation at the National TB Program.

DR. MILO RICHARDS,


Philippe Stoesslé has been working on the psychosocial factors leading to low adherence to TB treatment and he is currently developing a research project on TB among Central American undocumented immigrants in journey to the México-US border; generating new information in the sociology, health-related behaviors, risk factors and epidemiology of this population.

MR. PHILIPPE STOESSLÉ,

Marie Lucie Valesco is a registered nurse who works at the HIV

division of St. Michel hospital in Jacmel South East, Haiti. She is

responsible for community and ambulatory care since 2011 after

four years of hard work with other organizations to support

patients in need.

MS. MARIE LUCIE VALESCO,

Matthew Saunders is a medical doctor who trained in Birmingham and Liverpool, UK. He is currently working as a Clinical Research Fellow for IFHAD: Innovation for Health and Development, Peru aiming to work towards a PhD. His main interests include understanding the determinants of susceptibility to TB disease in people living with TB patients and evaluating socioeconomic interventions to improve uptake of screening and chemoprophylaxis in this group.

DR. MATTHEW SAUNDERS,

18


Travel Grant Awards NORTH AMERICA REGION

Guillaume Mullie is a second-year medical student at McGill University. In the summer of 2015, he joined the Respiratory Epidemiology and Clinical Research Unit of the Montreal Chest Institute. Conducted as part of the Research Bursary Program of the Faculty of Medicine at McGill, his work aims at assessing the cost-effectiveness of current screening practices for latent TB infection in North American health care workers.

MR. GUILLAUME MULLIE,

Ajibola Alabi is a fellow in pediatric infectious diseases at the Hospital for Sick Children, Toronto, Canada. She is a consultant pediatrician at Braithwaite Memorial Specialist Hospital, Rivers State, Nigeria. Her clinical and research interests include pediatric HIV/TB coinfection and the evaluation of clinical scoring systems for diagnosis of tuberculosis. Her current research project is related to hematologic abnormalities in children diagnosed with tuberculosis.

DR. AJIBOLA ALABI,

Dr. Marie-Claire Rowlinson is the Assistant Laboratory Director at the Bureau of Public Health Laboratories in Jacksonville. She joined Florida Department of Health in 2012 and oversees the infectious disease testing, including Mycobacteriology. The Mycobacteriology section has 18 staff and receives >20,000 samples a year. Dr. Rowlinson is continually looking for ways to improve TB diagnostics, using state of the art techniques and algorithms to rapidly and accurately diagnose TB and detect drug resistance.

DR. MARIE-CLAIRE ROWLINSON,

Rachel Padilla is currently an undergraduate student at Cornell University where she is majoring in Biological Sciences and concentrating in Cell and Molecular Biology. She worked as a research assistant this past summer at the RISE Tuberculosis Clinic at The Miriam Hospital in Providence, Rhode Island. Her career plans are focused on medical school and also obtaining a masters degree in public health.

MS. RACHEL PADILLA,


Travel Grant Awards NATIONAL TB CONTROLLERS ASSOCIATION

DR. HILLARY DUNLEVY,

DR. BIJAN GHASSEMIEH,

DR. GAYATRI MIRANI,

DR. WIGDAN FARAH,

NATIONAL TB NURSE COALITION MS. MARYBETH CARUSO,

MS. AMANDA GARRITY,

MS. TIFFANY HSU,

MS. BETH ANN MERTZ,

MS. DARLENE MORSE,

MS. KITTY SMITH,

NATIONAL SOCIETY OF TB CLINICIANS

SOCIETY FOR EPIDEMIOLOGY IN TB CONTROL DR. DOUGLAS PROOPS ,

MR. CHRISTOPHER ROGERS,

MS. ARGITA SALINDRI,

MS. NATALIE STENNIS,

MS. KATELYNNE GARDNER TOREN,

MS. SHAQUINA WHITE,

DR. CALIN CHIRIBAU,

Calin Chiribau has received his PhD title in 2005 and has been working at the Florida Bureau of Public Health Laboratories since 2013. He is currently the supervisor of the Mycobacteriology and Mycology Laboratory and manages a team of 18 medical laboratory scientists. Main professional interests are related to early adoption and integration of molecular-based methods for MTBC detection, identification and determination of drug resistance.

20


7:00 am-5:00 pm REGISTRATION

8:00 am-4:30 pm TB Survivor Communications Training (Tower Court D)

8:00 am-2:30 pm Annual Meeting of the US-Affiliated Pacific Islands TB Control Programs (Tower

Court C)

12:00-4:00 pm NTCA Board Meeting (Tower Court A)

1:00-4:30 pm Challenges and Issues in Ensuring High Quality TB Surveillance Data (Tower Court B)

2:30-4:30 pm Targeted Outreach Strategies for High-TB Burden Populations: A Discussion Forum

(Windows)

5:00-6:00 pm NTCA Business Meeting (Grand Ballroom I)

6:00-7:00 pm NTCA Town Hall (Grand Ballroom I)

AGENDA: TUESDAY, February 23, 2016


8:00 am-12:30 pm TB Survivor Communications Training (Tower Court D)

8:00 am-1:30 pm NTCA SECTION MEETINGS

NSTC Annual Meeting: Guidelines Update and Beyond the Cookbook (There’s No Recipe for That!) (Grand Ballroom I) IGRA Best Practices Dr. Lisa Armitige, Heartland National TB Center, San Antonio, TX, USA Xpert for Release from Isolation Dr. John Bernardo, Boston University School of Medicine, Boston, MA, USA Beyond the Cookbook (There’s No Recipe for That!) Exploding Head Zone – The Interface of Molecular and Growth-Based Drug Susceptibility

Testing Dr. Ed Desmond, California Department of Public Health, Richmond, CA, USA What in the World Are We Going to do About Childhood Tuberculosis? Dr. Jeffrey Starke, Baylor Medical Center, Houston, TX, USA When Patients’ Needs Exceed Available Resources—What Do I Do and Where Can I Turn?

NTNC Annual Meeting: Learning from the Past-Preparing for the Future (Grand Ballroom II) A. Learning from the Past: MDR-TB: What Nurses Can Do to Make Treatment Bearable MDR-TB: Patient and Provider Experience Ms. Michelle Haas, Denver, CO, USA Managing MDR-TB in a Low Incidence State Mr. Larry Niler, Utah Department of Health, Salt Lake City, UT, USA

AGENDA: WEDNESDAY, February 24, 2016


B. Preparing for the Future: Partnerships to Treat LTBI, Training New TB Nurses, and Contributing to the Development of TB Guidelines Partnerships with Providers in Homeless Communities Ms. April King-Todd, Los Angeles County Department of Public Health, Los Angeles, CA, USA Update/Demo of TB Training Roadmap for Public Health Nurses Developed by the Global Institute for TB Ms. Patty Woods and Nisha Ahamed, Rutgers Global TB Institute, Newark, NJ, USA

SETC Annual Meeting: Talking Shop in the Mile-High City (Tower Court A) Overview of Member Profiles, Year in Review, NTCA Liaison/Workgroup Reports, SETC Workgroup Updates, Open Forum

2:00-6:00 pm POST-GRADUATE COURSES

A. Using Epidemiology for Data-Driven Decision-Making in TB Programs Training Goals (Grand Ballroom I) Provide an overview of how epidemiology can be used today and in the future to control, prevent,

and eliminate TB Highlight best epidemiological practices currently used in North America Region Discuss how to present TB data to influence decision-makers Introduce, discuss new available tools

B. Digital Tools and Social Media for Public Health (Tower Court D) Training Goals: Learn how to get your message across using social media Learn to set-up social media profiles Target the right audience Develop effective messages Leverage boosting tools offered by these media Carry out strong campaigns and get your message across

C. Advances in the Science and Practice in Tuberculosis Control (Grand Ballroom II) Training Goals: To familiarize TB clinicians and scientists with the latest thinking on the state of latency of

Mycobacterium tuberculosis and the latest approaches to treatment of LTBI to prevent reactivation. To familiarize TB clinicians and scientists with the latest thinking on airborne transmission and the

aerobiology of Mycobacterium tuberculosis, the rapid impact of treatment on transmission, and how this information informs current thinking on isolation and quarantine policies for patients.

2:00-3:00 pm

Latency The Spectrum of Ideas about TB Latency Dr. David R. Sherman, Seattle Biomedical Research Institute, Seattle, WA, USA Latent TB: Simplifying the Clinical Approach to a Complex Biologic Disease Dr. Robert Belknap, Denver Health, Denver, CO, USA

3:00-3:30 pm Whole Genome Sequencing

Microbiome Approaches for TB/NTM Diagnostics Dr. Rebecca Davidson, National Jewish Health, Denver, CO, USA

3:30-4:00 pm Break

4:00-4:30 pm Whole Genome Next Generation Sequencing of TB in a Public Health Laboratory: A New Diagnostic Era Dr. Kimberlee Musser, New York State Department of Health, Albany, NY, USA

22


AGENDA: THURSDAY, February 25, 2016 GRAND BALLROOM

4:30-5:30 pm Airborne Infection and Isolation

Short Case Presentation & Impact of Effective Treatment on Transmission and Transcriptomics on Captured Aerosol Dr. Edward Nardell, Harvard School of Public Health, Boston, MA, USA

Treatment Rapidly Alters the Physiologic State of M. tuberculosis in Sputum Dr. Nick Walter, Denver VA Medical Center, Denver, CO, USA

Preventing Transmission of TB: Research and Reality Dr. Kevin Fennelly, National Institutes of Health, Bethesda, MD, USA

6:00-8:00 pm NAR Council/Executive Committee Meeting (Aspen Room)


8:00-8:10 am Opening and Welcome Remarks Ms. Nora Rodriguez and Ms. Carrie Fritschy

8:10 am-12:00 pm

Stop TB Meeting: Global and Regional Challenges in TB Elimination Chairs: Drs. Elizabeth Rea, Lisa Pascopella and Randall Reves

VIDEOCONFERENCING

8:10-8:55 am Progress, Challenges Toward the Goal of Global TB Elimination Dr. Knut Lönnroth, World Health Organization, Geneva, Switzerland

8:55-9:25 am Epidemiological Modelling of TB Elimination Dr. David Dowdy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

9:25-9:35 am Oral Abstract Presentation: Identifying Gaps in Tuberculosis Prevention among Adults at an Urban, Public Health Clinic: An LTBI Care Continuum Dr. Hillary Dunlevy, University of Colorado Infectious Diseases, Aurora, CO, USA

9:35-10:00 am Break

LIVE PRESENTATIONS

10:00-10:25 am TB Elimination in Canada: Can We Get There? Dr. Richard Long, University of Alberta, Edmonton, AB, Canada


10:25-10:50 am TB Elimination: “California Dreamin” Drs. Pennan Barry and Jennifer Flood, California Department of Public Health, Richmond, CA, USA

10:50-11:15 am TB Elimination in the Caribbean: The Suriname Experience Dr. Eric Commiesie, Ministry of Health, Paramaribo, Suriname

11:15-11:35 am

PAHO’s Pilot TB Program: Framework of TB Control in Large Cities Dr. Mirtha del Granado, PAHO, Washington, DC, USA

11:35-12:00 pm Panel Discussion

12:00-1:00 pm Lunch Break

Stop TB Canada Meeting (Tower Court A)

Stop TB USA Meeting (Tower Court D)

1:00-4:00 pm Nursing Sponsored Session – TB Elimination through Collaborative Partnerships Chairs: Ms. Carolyn Bargman, Lana Tyer, and Teresa Wortmann

1:00-1:05 pm Opening Remarks

1:05-1:35 pm Paramedics...Responding to More than Shootings and Heart Attacks Mr. Mike Taigman and Ms. Eva Reeder, American Medical Response, Ventura County Public Health, Ventura, CA, USA

1:35-2:35 pm 3 P’s: Pharmacist, Pills, and PPDs Ms. Diana Fortune, New Mexico Department of Public Health, Santa Fe, NM, USA Ms. Mai Vu, San Francisco VA Medical Center, San Francisco, CA, USA

2:35-2:50 pm Break

2:50-3:50 pm College Entrance: SAT, ACT and Now a TST and IGRA too? Ms. Teresa Wortmann, Missouri Department of Health and Senior Services, Jefferson City, MO, USA

Mr. Phil Griffin, Kansas Tuberculosis Control Program, Topeka, KS, USA

3:50-4:00 pm Oral Abstract Presentation: Family-Centered Approach to TB Care Ms. Lillian Pirog, NJMS Global Tuberculosis Institute Lattimore Practice, Newark, NJ, USA

4:00-5:00 pm Break

24


5:00-6:00 pm The Beyond TB Lecture - One Health: Beyond Medicine Dr. Francisco J. Olea-Popelka, The Union, Paris, France

6:00-7:00 pm The George Comstock Lecture - Global Scale-Up of the Management of Drug-Resistant Tuberculosis: Why is This So Hard? Dr. Charles Daley, National Jewish Health, Denver, CO, USA

7:15-9:00 pm

Industry-Sponsored Satellite Symposium 1 QuantiFERON - Insights for Research and Practitioners

8:00 am-12:00 pm Current Issues on Pediatric TB Chairs: Drs. Ian Kitai and Anna Mandalakas

8:00-8:05 am Introduction to TB Meningitis

8:05-8:15 am Case Presentation

8:15-8:40 am The Epidemiology, Clinical Characteristics and Outcomes of Pediatric Central Nervous System Tuberculosis in California from 1993-2011; A Search for Modifiable Clinical and Epidemiological Risk Factors Dr. Alexander Kay, California Department of Public Health, Richmond, CA, USA

8:40-9:05 am Treatment Outcomes of Childhood Tuberculous Meningitis: A Systematic Review of TB Meningitis Dr. Silvia Chiang, Baylor College of Medicine, Houston, TX, USA

9:05-9:30 am Panel Discussion

9:30-9:50 am Break

AGENDA: FRIDAY, February 26, 2016 GRAND BALLROOM

9:50-10:20 am New Approaches to the Diagnosis and Management of Tuberculosis Infection in Children and Adolescents Dr. Jeffrey Starke, Baylor Medical Center, Houston, TX, USA

10:20-11:20 am School Outbreaks and Exposures – Best Practices and Management Mr. Phil Griffin, Kansas Department of Health, Topeka, KS, USA Dr. Randall Reves, Denver Public Health Department, Denver, CO, USA Zee Pinkerton, Olathe, KS, USA



11:50 am-12:00 pm Oral Abstract Presentation: Latent Tuberculosis in Pregnancy: A Systematic Review Dr. Isabelle Malhamé, McGill University, Montreal, QC, Canada

12:00-1:30 pm Lunch Break (boxed lunches will be provided)

NAR Annual General Meeting

1:30-4:30 pm TB Genomics in Clinical and Public Health Practice Chairs: Drs. Jennifer Gardy and James Johnston

1:30-1:35 pm Introduction

1:35-2:00 pm Introduction to the TB Genome Dr. James Johnston, BC Centre for Disease Control, Vancouver, BC, Canada

2:00-2:30 pm The Impact of Genomics Era on Mycobacterium tuberculosis Research Dr. James Posey, Center for Disease Control, Atlanta, GA, USA

2:30-3:00 pm Implementing WGS as Clinical Decision Making Tool Dr. Shaheed Vally Omar, South African National Institute for Communicable Disease, Cape Town, South Africa

3:00-3:20 pm Break

3:20-3:50 pm Tracking TB in the Canadian North: Detecting Outbreaks among Founder Strains Dr. Robyn Lee, McGill University, Montreal, QC, Canada

3:50-4:20 pm Reconstructing TB Outbreaks with Genomics: Lessons from an Outbreak in BC Homeless Shelter Dr. Jennifer Gardy, BC Centre for Disease Control, Vancouver, BC, Canada

4:20-4:30 pm Oral Abstract Presentation: Surveillance for Large Outbreaks of Tuberculosis in the United States, 2014 to 2015 Dr. Thomas Navin, Centers for Disease Control and Prevention, Atlanta, GA, USA

4:30-5:30 pm Awards Ceremony

5:00-7:00 pm Poster Session

26


7:00-8:00am Meet the Professor

8:30am-11:45am Public Health is Local: One Size Doesn’t Fit All Chair: Dr. John Bernardo

8:30-8:50 am Overview of the Unaccompanied Children with TB Dr. John Jereb, Office of Refugee Resettlement, Washington, DC, USA

8:50-9:10 am Texas Interfaith Welcome Coalition: Personal Perspectives Ms. Catalina Navarro, Heartland National TB Center, San Antonio, TX, USA

9:10-9:30 am Homelessness, Housing, and Tuberculosis: The National Picture Dr. Sapna Morris, Centers for Disease Control and Prevention, Atlanta, GA, USA

9:30-9:45 am Break

AGENDA: SATURDAY, February 27, 2016 GRAND BALLROOM

9:45-10:05 am The Local Picture: Atlanta, Georgia Dr. Susan Ray, Emory University, Atlanta, GA, USA

10:05-10:25 am The Local Picture: Seattle King County, Washington Dr. Masa Narita, Public Health Seattle, Seattle, WA, USA

10:45-11:05 am HUD: National Program with Housing Solutions Mr. David Canavan, HUD, Washington, DC, USA

11:05-11:15 am Oral Abstract Presentation: Cost-Effectiveness of Targeted Testing and Treatment for Latent Tuberculosis Infection among Foreign-born Persons in the United States Dr. Jessica Yeats, RAND Graduate School, RAND Corporation, Los Angeles, CA, USA


11:45 am-1:30 pm Lunch Break

12:00-1:15 pm

Industry–Sponsored Satellite Symposium 2 Diabetes & Tuberculosis: Converging Epidemics and their Impact on Patient Care


1:30-4:30 pm Drug Resistant Session

Chairs: Drs. Sundari Mase and Barbara Seaworth

1:30-2:00 pm Treatment of MDR in Pregnancy; Results of a Systematics Review Dr. Farah Parvez, Centers for Disease Control and Prevention, Atlanta, GA, USA

2:00-2:30 pm Low Level Rifampin Resistance: Diagnostic Challenges and Treatment Outcomes Dr. Neha Shah, Centers for Disease Control and Prevention, Atlanta, GA, USA

2:30-3:00 pm Impact of the Number of Drugs, Treatment Duration and PZA on MDR TB Treatment Outcomes Dr. Carole Mitnick, Partners in Health, Harvard University, Boston, MA, USA

3:00-3:30 pm Break

3:30-4:00 pm Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and its Newer Relatives Dr. Maunank Shah, Johns Hopkins University, Baltimore, MD, USA

4:00-4:20 pm Panel Discussion

4:20-4:30 pm Oral Abstract Presentation: Enhancing Management of Tuberculosis Treatment with Video Directly Observed Therapy Dr. Michelle Macaraig, New York City Department of Health and Mental Hygiene, Queens, NY, USA

4:30-4:40 pm Closing Remarks

5:00-6:00 pm Post Conference Meeting and 2017 Planning (Tower Court D)

28


GOLD SPONSORS

EXHIBITORS

SUPPORTING ORGANIZATIONS

Pittsfield Anti-Tuberculosis

Association

Aeras

Centers for Disease Control

Cepheid

Consilience Software, A XEROX Company

Curry International Tuberculosis Center

emocha

Firland Northwest TB Training Center

Heartland National TB Center

IMMY

Mayo Clinic Center for Tuberculosis

Rutgers/NJMS Global TB Institute

Sanofi

Southeastern National Tuberculosis Center

STOP TB USA

SureAdhere

National TB Controllers Association

RESULTS International

The Union

Thermo Fisher Scientific

BRONZE SPONSOR

abstractcover2016...ebony irby the union—nar new york, ny, usa president-elect: victoria cook, md...

Documents